| Message: | Product Name Rivastigmine Tartrate
Rivastigmine Tartrate Alias Rivastigmine-d6 tartarate
Rivastigmine Tartrate CAS 129101-54-8
Rivastigmine Tartrate MF C18H28N2O8
Rivastigmine Tartrate MW 400.4235
Rivastigmine Tartrate Purity 99%
Rivastigmine Tartrate MP 123-125°C
Rivastigmine Tartrate BP 316.2°C at 760 mmHg
Rivastigmine Tartrate FP 145°C
Grade Pharmaceutical Grade
Appearance White Powder
Rivastigmine Tartrate is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
Pharmacological Effects
Rivastigmine Tartrate is rivastigmine Alzheimer's disease drugs, rivastigmine is physostigmine derivative by Novartis for the first time successfully developed the trade name Exelon (exelon), a molecule with there carbamate structure, is a kind of amino acid of selective cerebral cholinesterase inhibitor, can also inhibit the acetylcholinesterase and butyrylcholinesterase, cholinergic neurons by delaying the release of acetylcholine degradation and energy promoting cholinergic nerve conduction, can improve cognitive function disorders mediated by cholinergic, thereby improving the cognitive function of Alzheimer's disease patients. |
my account
